Subcutaneous immunoglobulin for the treatment of deep morphoea in a child.
Clin Exp Dermatol
; 43(3): 303-305, 2018 Apr.
Article
em En
| MEDLINE
| ID: mdl-29280519
ABSTRACT
Morphoea, also known as localized scleroderma, is a disorder characterized by excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues. Intravenous IgG therapy has induced improvement in some fibrotic conditions. The primary indication for subcutaneous IgG (SCIG) is in primary immunodeficiency disorders as replacement therapy; however, recently there has been considerable interest in SCIG as an immunomodulatory agent. We report an 11-year-old girl with deep morphoea who was successfully treated with SCIG.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esclerodermia Localizada
/
Imunoglobulina G
Limite:
Child
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article